Literature DB >> 29984788

Renal Dysfunction Affects Anticoagulation Control With Warfarin and Outcomes in Japanese Elderly Patients With Non-Valvular Atrial Fibrillation.

Hiroshi Inoue1, Eitaro Kodani2, Hirotsugu Atarashi2, Ken Okumura3, Takeshi Yamashita4, Hideki Origasa5.   

Abstract

BACKGROUND: It is unclear whether renal dysfunction affects warfarin control in patients with non-valvular atrial fibrillation (NVAF). Methods and 
Results: Using a dataset from the J-RHYTHM Registry, time in therapeutic range (TTR) of the international normalized ratio (INR) of prothrombin time, and creatinine clearance (CrCl) were determined in elderly patients aged ≥70 years. Target INR values were 1.6-2.6 following Japanese guidelines. Incidences of thromboembolism, major hemorrhage, and all-cause death were determined over 2 years. Of 7,406 NVAF patients enrolled in the registry, 2,782 elderly patients (mean age, 75 years) had data for CrCl measured at baseline and TTR. TTR values were lower in the lower CrCl groups (P<0.001 for trend). CrCl <30 mL/min was independently associated with TTR <65% (odds ratio, 1.49; 95% confidence interval, 1.13-1.95; P=0.004). In the multivariate analysis, TTR <65% was independently associated with thromboembolism (hazard ratio, 2.26; 95% confidence interval, 1.37-3.72; P=0.001), but CrCl was not (CrCl <30 mL/min, 1.68, 0.41-6.85, P=0.473). However, CrCl <30 mL/min and TTR <65% were independently associated with all-cause death (5.32, 1.56-18.18, P=0.008 and 1.60, 1.07-2.38, P=0.022, respectively) and the composite event (thromboembolism, major hemorrhage and all-cause death) (2.03, 1.10-3.76, P=0.024 and 1.58, 1.22-2.04, P=0.001, respectively).
CONCLUSIONS: Elderly NVAF patients with renal dysfunction had poor warfarin control, which was associated with higher risk of thromboembolism and all-cause death.

Entities:  

Keywords:  Atrial fibrillation; Elderly; Renal dysfunction; Warfarin control

Year:  2018        PMID: 29984788     DOI: 10.1253/circj.CJ-18-0242

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  3 in total

1.  Moderate chronic kidney disease and left atrial enlargement independently predict thromboembolic events and mortality in elderly patients with atrial fibrillation: a retrospective single-center study.

Authors:  Hai-Jun Wang; Kai-Liang Li; Jian Li; Kun Lin; Yang Shi; Hao Wang; Quan-Jin Si; Yu-Tang Wang
Journal:  J Int Med Res       Date:  2019-07-21       Impact factor: 1.671

2.  Predictive ability of creatinine clearance versus estimated glomerular filtration rate for outcomes in patients with non-valvular atrial fibrillation: Subanalysis of the J-RHYTHM Registry.

Authors:  Eitaro Kodani; Hiroshi Inoue; Hirotsugu Atarashi; Hirofumi Tomita; Ken Okumura; Takeshi Yamashita; Hideki Origasa
Journal:  Int J Cardiol Heart Vasc       Date:  2020-06-10

3.  Ischemic stroke, hemorrhage, and mortality in patients with non-valvular atrial fibrillation and renal dysfunction treated with rivaroxaban: sub-analysis of the EXPAND study.

Authors:  Hirotsugu Atarashi; Shinichiro Uchiyama; Hiroshi Inoue; Takanari Kitazono; Takeshi Yamashita; Wataru Shimizu; Takanori Ikeda; Masahiro Kamouchi; Koichi Kaikita; Koji Fukuda; Hideki Origasa; Hiroaki Shimokawa
Journal:  Heart Vessels       Date:  2021-03-16       Impact factor: 2.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.